Cytokinetics Confirms Failed Acquisition Talks at June 5 Jefferies Conference

Cytokinetics Inc. (CYTK) has confirmed that acquisition talks with a third party took place late last year but did not result in a deal. CEO Robert Blum and the company's board engaged in good faith discussions, but the third party ultimately decided not to move forward with the acquisition. The disclosure was made during the Jefferies Healthcare Conference on June 5 at 10 am, where further details on recent events and regulatory timelines were anticipated. Investors were particularly interested in the company's explanation and defensive stance on the failed negotiations, especially after the big offering.